| Nome |
# |
|
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy., file e3ad8916-90be-da0e-e053-3705fe0a2b96
|
699
|
|
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study., file e3ad8916-d6ae-da0e-e053-3705fe0a2b96
|
617
|
|
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy, file e3ad891c-77e3-da0e-e053-3705fe0a2b96
|
518
|
|
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature., file e3ad8916-9109-da0e-e053-3705fe0a2b96
|
516
|
|
Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis., file e3ad8916-8801-da0e-e053-3705fe0a2b96
|
467
|
|
Esophageal motility changes after thyroidectomy:
possible associations with postoperative voice
and swallowing disorders, file e3ad8916-7110-da0e-e053-3705fe0a2b96
|
461
|
|
Clinical course and management of acute and chronic viral hepatitis during pregnancy., file e3ad8916-d223-da0e-e053-3705fe0a2b96
|
418
|
|
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication., file e3ad891a-5888-da0e-e053-3705fe0a2b96
|
337
|
|
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases, file e3ad891b-9421-da0e-e053-3705fe0a2b96
|
322
|
|
HCV Prevalence in Italy an Epidemiological, Observational, Cross-Sectional, Multicenter Study Participating Centers., file e3ad8916-8c24-da0e-e053-3705fe0a2b96
|
320
|
|
Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction, file e3ad8918-a8f9-da0e-e053-3705fe0a2b96
|
317
|
|
Interaction of alcohol intake and cofactors on the risk of cirrhosis., file e3ad8916-8601-da0e-e053-3705fe0a2b96
|
303
|
|
Unusual B cell morphology in inflammatory bowel disease., file e3ad8916-877f-da0e-e053-3705fe0a2b96
|
295
|
|
Current practice of chronic hepatitis B treatment in Southern Italy., file e3ad8916-68f8-da0e-e053-3705fe0a2b96
|
258
|
|
A functional study of the esophagus in patients with non-cardiac chest pain and dysphagia, file e3ad8919-d760-da0e-e053-3705fe0a2b96
|
255
|
|
Pegylated-interferon-α(2a) in clinical
practice: how to manage patients suffering from side effects, file e3ad8916-54fb-da0e-e053-3705fe0a2b96
|
253
|
|
Esophageal motility changes after thyroidectomy; possible associations with postoperative voice and swallowing disorders: preliminary results., file e3ad8916-64b5-da0e-e053-3705fe0a2b96
|
245
|
|
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b, file e3ad891a-7651-da0e-e053-3705fe0a2b96
|
239
|
|
Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveys, file e3ad891f-03ac-da0e-e053-3705fe0a2b96
|
239
|
|
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions., file e3ad8916-5637-da0e-e053-3705fe0a2b96
|
238
|
|
Current practice of hepatitis C treatment in Southern Italy., file e3ad8916-8887-da0e-e053-3705fe0a2b96
|
237
|
|
Hepatitis delta infection in Italian patients: towards the end of the story?, file e3ad891c-a48b-da0e-e053-3705fe0a2b96
|
234
|
|
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology, file e3ad891b-89db-da0e-e053-3705fe0a2b96
|
219
|
|
Management of hepatitis C virus genotype 4: recommendations of an international expert panel., file e3ad8916-9107-da0e-e053-3705fe0a2b96
|
205
|
|
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study, file e3ad891b-d514-da0e-e053-3705fe0a2b96
|
197
|
|
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication, file e3ad891c-8ce3-da0e-e053-3705fe0a2b96
|
180
|
|
Impact of comorbidities on the severity of chronic hepatitis B at presentation., file e3ad8916-887e-da0e-e053-3705fe0a2b96
|
176
|
|
Liver function test abnormalities in patients with inflammatory bowel diseases: A hospital-based survey, file e3ad8916-d684-da0e-e053-3705fe0a2b96
|
174
|
|
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis, file e3ad8922-03c2-da0e-e053-3705fe0a2b96
|
153
|
|
Necrotizing Soft Tissue Fasciitis after Intramuscular Injection, file e3ad891e-a842-da0e-e053-3705fe0a2b96
|
142
|
|
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial., file e3ad8916-d6fe-da0e-e053-3705fe0a2b96
|
137
|
|
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy, file e3ad891f-03aa-da0e-e053-3705fe0a2b96
|
136
|
|
Granular cell tumor of stomach: a case report and review of literature., file e3ad891d-824f-da0e-e053-3705fe0a2b96
|
130
|
|
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C., file e3ad8919-a568-da0e-e053-3705fe0a2b96
|
129
|
|
B lymphocyte intestinal homing in inflammatory bowel disease., file e3ad8916-8880-da0e-e053-3705fe0a2b96
|
126
|
|
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance, file e3ad8916-5e58-da0e-e053-3705fe0a2b96
|
125
|
|
Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens., file e3ad8916-8c22-da0e-e053-3705fe0a2b96
|
125
|
|
Impact of hepatitis C virus infection on lifestyle., file e3ad891d-4d7a-da0e-e053-3705fe0a2b96
|
116
|
|
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study, file e3ad8916-a3ff-da0e-e053-3705fe0a2b96
|
108
|
|
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C, file e3ad8915-91de-da0e-e053-3705fe0a2b96
|
100
|
|
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways, file e3ad8921-d3dc-da0e-e053-3705fe0a2b96
|
95
|
|
Significance of serum Il-9 levels in inflammatory bowel disease, file e3ad8922-03ae-da0e-e053-3705fe0a2b96
|
89
|
|
Perception of the role of food and dietary modifications in patients with inflammatory bowel disease: Impact on lifestyle, file e3ad8928-ba25-da0e-e053-3705fe0a2b96
|
73
|
|
Hepatitis delta infection in Italian patients: towards the end of the story?, file e3ad891e-7c64-da0e-e053-3705fe0a2b96
|
62
|
|
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency., file e3ad8916-db7a-da0e-e053-3705fe0a2b96
|
58
|
|
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort, file e3ad891a-d257-da0e-e053-3705fe0a2b96
|
41
|
|
Tumor Necrosis Factor Alpha Antagonists and Occurrence of Autoantibodies in Inflammatory Bowel Disease Patients: A Single Center Experience, file e3ad8919-5d26-da0e-e053-3705fe0a2b96
|
32
|
|
TUMORI a CELLULE GERMINALIin ETA' PEDIATRICA: FATTORI PROGNOSTICI del PROTOCOLLO AIEOP TCG 91., file e3ad891b-d33b-da0e-e053-3705fe0a2b96
|
19
|
|
DISTRIBUTION OF ESOPHAGEAL DYSMOTILITIES AMONG PATIENTS WITH NON-CARDIAC CHEST PAIN, DYSPHAGIA OR BOTH, file e3ad8916-6ef6-da0e-e053-3705fe0a2b96
|
17
|
|
Diabetic foot ulcers: Retrospective comparative analysis from Sicily between two eras, file e3ad8928-4911-da0e-e053-3705fe0a2b96
|
16
|
|
MECCANISMI IMMUNOLOGICI E MOLECOLARI DEL DANNO EPATICO DA FARMACI, file e3ad8916-9f7f-da0e-e053-3705fe0a2b96
|
15
|
|
Predictive factors of polycystic ovary syndrome in girls with precocious pubarche, file e3ad8928-58f5-da0e-e053-3705fe0a2b96
|
14
|
|
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol, file e3ad8915-9bc4-da0e-e053-3705fe0a2b96
|
12
|
|
A woman with a long history of abdominal pain, file e3ad891a-8fd4-da0e-e053-3705fe0a2b96
|
9
|
|
Meccanismi immunologici e molecolari del danno epatico da farmaci, file e3ad891f-edab-da0e-e053-3705fe0a2b96
|
7
|
|
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C, file e3ad8919-a03e-da0e-e053-3705fe0a2b96
|
6
|
|
Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy, file e3ad8921-7e16-da0e-e053-3705fe0a2b96
|
3
|
|
Small bowel angiodysplasia associated with von Willebrand's disease: report of a case, file e3ad8919-e62e-da0e-e053-3705fe0a2b96
|
2
|
|
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection, file e3ad8919-f53d-da0e-e053-3705fe0a2b96
|
2
|
|
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C., file e3ad891d-a448-da0e-e053-3705fe0a2b96
|
2
|
|
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy, file e3ad891e-e731-da0e-e053-3705fe0a2b96
|
2
|
|
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases, file e3ad891f-01eb-da0e-e053-3705fe0a2b96
|
2
|
|
Erratum: Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy (European Journal of Gastroenterology and Hepatology (2018) 30 (676-681) DOI: 10.1097/MEG.0000000000001099), file e3ad8921-43a5-da0e-e053-3705fe0a2b96
|
2
|
|
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials, file e3ad8921-d43c-da0e-e053-3705fe0a2b96
|
2
|
|
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study, file e3ad8916-7888-da0e-e053-3705fe0a2b96
|
1
|
|
Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study*., file e3ad891d-6ecc-da0e-e053-3705fe0a2b96
|
1
|
|
End-stage pancreatic adenocarcinoma presenting as a sister Mary Joseph's nodule, file e3ad8921-b54a-da0e-e053-3705fe0a2b96
|
1
|
|
Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease, file e3ad8921-cd54-da0e-e053-3705fe0a2b96
|
1
|
|
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey, file e3ad8921-d9ff-da0e-e053-3705fe0a2b96
|
1
|
|
12 weeks of interferon-based therapy is feasible in patients with hepatitis C-related cirrhosis and thrombocytopenia: A post hoc analysis of eltrombopag studies, file e3ad8921-dd66-da0e-e053-3705fe0a2b96
|
1
|
|
Etiological factors of chronic hepatitis in Italy: A 2014 national survey, file e3ad8922-03c4-da0e-e053-3705fe0a2b96
|
1
|
|
Recurrent sacrococcygeal pilonidal disease: the efficacy of minimal subcutaneous excision of the sinus and unroofing of pseudocystic cavity, file e3ad8924-0838-da0e-e053-3705fe0a2b96
|
1
|
|
The association between education level and chronic liver disease of any etiology, file e3ad8926-e126-da0e-e053-3705fe0a2b96
|
1
|
|
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)), file e3ad8928-c018-da0e-e053-3705fe0a2b96
|
1
|
| Totale |
11.058 |